Paul B Chapman (Paul Chapman)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Topics

Peripheral Blood

Atopic Dermatitis

Ejection Fraction

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

James W Smithy, Hannah L Kalvin, Fiona D Ehrich, Ronak H Shah, Matthew J Adamow, Vladislav Raber, Colleen A Maher, Jenna Kleman, Deborah A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, Omar Eton, Suresh G Nair, Jedd D Wolchok, Paul B Chapman, Michael F Berger, Katherine S Panageas, Michael A Postow
Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
James W Smithy, Hannah L Kalvin, Fiona D Ehrich, Ronak H Shah, Matthew J Adamow, Vladislav Raber, Colleen A Maher, Jenna Kleman, Deborah A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, Omar Eton, Suresh G Nair, Jedd D Wolchok, Paul B Chapman, Michael F Berger, Katherine S Panageas, Michael A Postow
Early on-treatment assessment of T-cells, cytokines and tumor DNA with adaptively-dosed nivolumab + ipilimumab: final results from the phase 2 ADAPT-IT study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
James W Smithy, Hannah L Kalvin, Fiona D Ehrich, Ronak H Shah, Matthew J Adamow, Vladislav Raber, Colleen A Maher, Jenna Kleman, Deborah A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, Omar Eton, Suresh G Nair, Jedd D Wolchok, Paul B Chapman, Michael F Berger, Katherine S Panageas, Michael A Postow
Early on-treatment assessment of T-cells, cytokines and tumor DNA with adaptively-dosed nivolumab + ipilimumab: final results from the phase 2 ADAPT-IT study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
James W Smithy, Hannah L Kalvin, Fiona D Ehrich, Ronak H Shah, Matthew J Adamow, Vladislav Raber, Colleen A Maher, Jenna Kleman, Deborah A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, Omar Eton, Suresh G Nair, Jedd D Wolchok, Paul B Chapman, Michael F Berger, Katherine S Panageas, Michael A Postow
Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
James W Smithy, Hannah L Kalvin, Fiona D Ehrich, Ronak H Shah, Matthew J Adamow, Vladislav Raber, Colleen A Maher, Jenna Kleman, Deborah A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, Omar Eton, Suresh G Nair, Jedd D Wolchok, Paul B Chapman, Michael F Berger, Katherine S Panageas, Michael A Postow
Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Paul B Chapman, Mark G Klang, Michael A Postow, Alexander N Shoushtari, Ryan J Sullivan, Jedd D Wolchok, Taha Merghoub, Sadna Budhu, Phillip Wong, Margaret K Callahan, Bin Zheng, Jonathan H Zippin
Phase Ib trial of phenformin in patients with V600-mutated melanoma receiving dabrafenib and trametinib. Cancer research communications (2023)
Thomas M Atkinson, Jennifer L Hay, Soo Young Kim, Elizabeth Schofield, Michael A Postow, Parisa Momtaz, Allison Betof Warner, Alexander N Shoushtari, Margaret K Callahan, Jedd D Wolchok, Yuelin Li, Paul B Chapman
Decision-Making and Health-Related Quality of Life in Patients with Melanoma Considering Adjuvant Immunotherapy. The oncologist (2023)
Alyce Mei-Shiuan Kuo, Stephanie Gu, Joseph Stoll, Andrea P Moy, Stephen W Dusza, Allison Gordon, Elena C Haliasos, Yelena Janjigian, Lukas Kraehenbuehl, Elizabeth A Quigley, Paul B Chapman, Mario E Lacouture, Alina Markova
Management of immune-related cutaneous adverse events with dupilumab. Journal for immunotherapy of cancer 11 (6) (2023)
Thomas M Atkinson, Jennifer L Hay, Soo Young Kim, Elizabeth Schofield, Michael A Postow, Parisa Momtaz, Allison Betof Warner, Alexander N Shoushtari, Margaret K Callahan, Jedd D Wolchok, Yuelin Li, Paul B Chapman
Decision-Making and Health-Related Quality of Life in Patients with Melanoma Considering Adjuvant Immunotherapy. The oncologist (2023)
Claire F Friedman, Christine Spencer, Christopher R Cabanski, Katherine S Panageas, Daniel K Wells, Antoni Ribas, Hussein A Tawbi, Katy Tsai, Michael A Postow, Alexander N Shoushtari, Paul B Chapman, Joyson Karakunnel, Samantha Bucktrout, Pier Gherardini, Travis J Hollmann, Richard O Chen, Margaret Callahan, Theresa LaVallee, Ramy Ibrahim, Jedd Wolchok
Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translational biomarker analyses. Journal for immunotherapy of cancer 10 (1) (2022)
Paul B Chapman, Vetri Sudar Jayaprakasam, Katherine S Panageas, Margaret Callahan, Michael A Postow, Alexander N Shoushtari, Jedd D Wolchok, Allison Betof Warner
Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab. Journal for immunotherapy of cancer 9 (10) (2022)
Margaret K Callahan, Paul B Chapman
PD-1 or PD-L1 Blockade Adds Little to Combination of BRAF and MEK Inhibition in the Treatment of BRAF V600-Mutated Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (13) (2022)
Michael A Postow, Deborah A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, James W Smithy, Ellesa Naito, Marina K Cugliari, Vladislav Raber, Omar Eton, Suresh G Nair, Katherine S Panageas, Jedd D Wolchok, Paul B Chapman
Adaptive Dosing of Nivolumab + Ipilimumab Immunotherapy Based Upon Early, Interim Radiographic Assessment in Advanced Melanoma (The ADAPT-IT Study). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (10) (2021)
Paul B Chapman
Targeting Tumor-Rejection Antigens in Melanoma With Tumor-Infiltrating Lymphocytes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (24) (2021)
Ronglai Shen, Michael A Postow, Matthew J Adamow, Arshi Arora, Margaret Hannum, Colleen Maher, Phillip Wong, Michael A Curran, Travis J Hollman, Liwei Jia, Hikmat A Al-Ahmadie, Niamh M Keegan, Samuel A Funt, Gopa Iyer, Jonathan E Rosenberg, Dean F Bajorin, Paul B Chapman, Alexander N Shoushtari, Allison Betof Warner, Parisa Momtaz, Taha Merghoub, Jedd D Wolchok, Katherine S Panageas, Margaret K Callahan
LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade. Science translational medicine 13 (608) (2021)
Paul B Chapman, Nathan J Liu, Qin Zhou, Alexia Iasonos, Sara Hanley, George J Bosl, David R Spriggs
Time to publication of oncology trials and why some trials are never published. PloS one 12 (9) (2017)